ETHYL 2-(TERT-BUTYLDIMETHYLSILYLOXY)ACETATE, 95.0%, 1g

Methyl 3-bromo-5-hydroxybenzoate, 95.0%, 100g

DL-Pyroglutamic Acid>99.0%(T)100g

8-Bromo-5-methylimidazo[1,2-a]pyridine hydrochloride, 95.0%, 1g

1-(5-Bromo-2-fluorophenyl)ethan-1-amine, 98%, 100mg

6-(trifluoromethyl)-1-benzofuran-3-ol, 98%, 250mg

(1R,2R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclopentanecarboxylic acid, 95.0%, 1g

Oxyde de magnésium, minimum 98 %, Ph.Eur., USP, granulé, 500 g, emballage plastique.

1-(4-Chloro-3-methylbenzyl)piperidin-4-one, 10g

2-Ethynyl-1,1'-biphenyl, 97%, 1g

N-methyl-2-(4-methyl-1H-benzimidazol-2-yl)ethanamine hydrochloride, 95.0%, 5g

tert-Butyl 4,4-difluoropiperidine-1-carboxylate, 95.0%, 1g

2,4-Dibromo-6-methylpyridine, 95.0%, 100g